Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00169039
Status:
TERMINATED
Last Update Posted:
2015-04-07
First Post:
2005-09-10
Brief Title:
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
Sponsor:
Harvard Medical School HMS and HSDM
Organization:
Harvard Medical School HMS and HSDM
Study Overview
Official Title:
Clozapine Response and Biogenic Amines in Schizophrenia
Status:
TERMINATED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will examine the physical response to clozapine or chlorpromazine in people with schizophrenia that has not improved with treatment
Detailed Description:
This is a longitudinal double-blind 12-week study of the clinical and biochemical response to clozapine or chlorpromazine in a group of treatment-refractory schizophrenic patients
The study has 4 phases 1 A recruitment period 2 a period of discontinuation of psychotropic medication 3 a drug-washout period and 4 a 12-week double-blind trial of clozapine or chlorpromazine
The study has 4 phases 1 A recruitment period 2 a period of discontinuation of psychotropic medication 3 a drug-washout period and 4 a 12-week double-blind trial of clozapine or chlorpromazine
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01MH049891 | NIH | None | httpsreporternihgovquickSearchR01MH049891 |